The EAT of patients with CAD overexpresses GLP-2R in comparison to GLP-1R expression, where GLP-2R is associated with increased fatty acid synthesis (FAS), and GLP-1R promotes fatty acid oxidation (FAO) and the transition of white adipose tissue (WAT) to brown adipose tissue (BAT) [116]. Here, GLP1R is linked to coronary artery disorder.